Wpływ suplementacji diety selenem na przebieg autoimmunologicznego zapalenia tarczycy – przegląd badań klinicznych przeprowadzonych w populacji europejskiej

[1]Caturegli P., De Remigis A., Chuang K., Dembele M., Iwama A., Iwama S.: Hashimoto’s thyroiditis: Celebrating the centennial through the lens of the Johns Hopkins Hospital surgical pathology records. Thyroid, 2013; 23: 142-150 Caturegli P. De Remigis A. Chuang K. Dembele M. Iwama A. Iwama S. Hashimoto’s thyroiditis: Celebrating the centennial through the lens of the Johns Hopkins Hospital surgical pathology records Thyroid 2013 23 142 15010.1089/thy.2012.0554356996623151083Search in Google Scholar

[2]Hiromatsu Y., Satoh H., Amino N.: Hashimoto’s thyroiditis: History and future outlook. Hormones, 2013; 12: 12-18 Hiromatsu Y. Satoh H. Amino N. Hashimoto’s thyroiditis: History and future outlook Hormones 2013 12 12 1810.1007/BF0340128223624127Search in Google Scholar

[3]Pearce E.N., Farwell A.P., Braverman L.E.: Thyroiditis. N. Engl. J. Med., 2003; 348: 2646-2655 Pearce E.N. Farwell A.P. Braverman L.E. Thyroiditis N. Engl. J. Med 2003 348 2646 265510.1056/NEJMra02119412826640Search in Google Scholar

[4]Bülow Pedersen I., Knudsen N., Carlé A., Schomburg L., Köhrle J., Jørgensen T., Rasmussen L.B., Ovesen L., Laurberg P.: Serum selenium is low in newly diagnosed Graves’ disease: A population-based study. Clin. Endocrinol., 2013; 79: 584-590 Bülow Pedersen I. Knudsen N. Carlé A. Schomburg L. Köhrle J. Jørgensen T. Rasmussen L.B. Ovesen L. Laurberg P. Serum selenium is low in newly diagnosed Graves’ disease: A population-based study Clin. Endocrinol 2013 79 584 59010.1111/cen.1218523448365Search in Google Scholar

[5]Glattre E., Nygård J.F., Aaseth J.: Selenium and cancer prevention: Observations and complexity. J. Trace Elem. Med. Biol., 2012; 26: 168-169 Glattre E. Nygård J.F. Aaseth J. Selenium and cancer prevention: Observations and complexity J. Trace Elem. Med. Biol 2012 26 168 16910.1016/j.jtemb.2012.04.02122664335Search in Google Scholar

[6]Rasmussen L.B., Schomburg L., Köhrle J., Pedersen I.B., Hollenbach B., Hög A., Ovesen L., Perrild H., Laurberg P.: Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur. J. Endocrinol., 2011; 164: 585-590 Rasmussen L.B. Schomburg L. Köhrle J. Pedersen I.B. Hollenbach B. Hög A. Ovesen L. Perrild H. Laurberg P. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency Eur. J. Endocrinol 2011 164 585 59010.1530/EJE-10-102621242171Search in Google Scholar

[7]Wu Q., Rayman M.P., Lv H., Schomburg L., Cui B., Gao C., Chen P., Zhuang G., Zhang Z., Peng X., Li H., Zhao Y., He X., Zeng G., Qin F., Hou P., Shi B.: Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab., 2015; 100: 4037-4047 Wu Q. Rayman M.P. Lv H. Schomburg L. Cui B. Gao C. Chen P. Zhuang G. Zhang Z. Peng X. Li H. Zhao Y. He X. Zeng G. Qin F. Hou P. Shi B. Low population selenium status is associated with increased prevalence of thyroid disease J. Clin. Endocrinol. Metab 2015 100 4037 404710.1210/jc.2015-222226305620Search in Google Scholar

[8]Aaseth J., Frey H., Glattre E., Norheim G., Ringstad J., Thomassen Y.: Selenium concentrations in the human thyroid gland. Biol. Trace Elem. Res., 1990; 24: 147-152 Aaseth J. Frey H. Glattre E. Norheim G. Ringstad J. Thomassen Y. Selenium concentrations in the human thyroid gland Biol. Trace Elem. Res 1990 24 147 15210.1007/BF029172021702666Search in Google Scholar

[9]Bermano G., Nicol F., Dyer J.A., Sunde R.A., Beckett G.J., Arthur J.R., Hesketh J.E.: Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem. J., 1995; 311: 425-430 Bermano G. Nicol F. Dyer J.A. Sunde R.A. Beckett G.J. Arthur J.R. Hesketh J.E. Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats Biochem. J 1995 311 425 43010.1042/bj311042511360177487877Search in Google Scholar

[10]Schomburg L.: Selenium, selenoproteins and the thyroid gland: Interactions in health and disease. Nat. Rev. Endocrinol., 2011; 8: 160-171 Schomburg L. Selenium, selenoproteins and the thyroid gland: Interactions in health and disease Nat. Rev. Endocrinol 2011 8 160 17110.1038/nrendo.2011.17422009156Search in Google Scholar

[11]Gärtner R., Gasnier B.C., Dietrich J.W., Krebs B., Angstwurm M.W.: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab., 2002; 87: 1687-1691 Gärtner R. Gasnier B.C. Dietrich J.W. Krebs B. Angstwurm M.W. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations J. Clin. Endocrinol. Metab 2002 87 1687 169110.1210/jc.87.4.1687Search in Google Scholar

[12]Gärtner R., Gasnier B.C.: Selenium in the treatment of autoimmune thyroiditis. Biofactors, 2003; 19: 165-170 Gärtner R. Gasnier B.C. Selenium in the treatment of autoimmune thyroiditis Biofactors 2003 19 165 17010.1002/biof.552019030914757967Search in Google Scholar

[13]Duntas L.H., Mantzou E., Koutras D.A.: Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol., 2003; 148: 389-393 Duntas L.H. Mantzou E. Koutras D.A. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis Eur. J. Endocrinol 2003 148 389 39310.1530/eje.0.148038912656658Search in Google Scholar

[14]Turker O., Kumanlioglu K., Karapolat I., Dogan I.: Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol., 2006; 190: 151-156 Turker O. Kumanlioglu K. Karapolat I. Dogan I. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses J. Endocrinol 2006 190 151 15610.1677/joe.1.0666116837619Search in Google Scholar

[15]Mazokopakis E.E., Papadakis J.A., Papadomanolaki M.G., Batistakis A.G., Giannakopoulos T.G., Protopapadakis E.E., Ganotakis E.S.: Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid, 2007; 17: 609-612 Mazokopakis E.E. Papadakis J.A. Papadomanolaki M.G. Batistakis A.G. Giannakopoulos T.G. Protopapadakis E.E. Ganotakis E.S. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis Thyroid 2007 17 609 61210.1089/thy.2007.004017696828Search in Google Scholar

[16]Karanikas G., Schuetz M., Kontur S., Duan H., Kommata S., Schoen R., Antoni A., Kletter K., Dudczak R., Willheim M.: No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 2008; 18: 7-12 Karanikas G. Schuetz M. Kontur S. Duan H. Kommata S. Schoen R. Antoni A. Kletter K. Dudczak R. Willheim M. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis Thyroid 2008 18 7 1210.1089/thy.2007.012718302514Search in Google Scholar

[17]Balázs C., Fehér J.: The effect of selenium therapy on autoimmune thyroiditis. Clin. Exp. Med. J., 2009; 3: 269-277 Balázs C. Fehér J. The effect of selenium therapy on autoimmune thyroiditis Clin. Exp. Med. J 2009 3 269 27710.1556/CEMED.3.2009.28408Search in Google Scholar

[18]Nacamulli D., Mian C., Petricca D., Lazzarotto F., Barollo S., Pozza D., Masiero S., Faggian D., Plebani M., Girelli M.E., Mantero F., Betterle C.: Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin. Endocrinol., 2010; 73: 535-539 Nacamulli D. Mian C. Petricca D. Lazzarotto F. Barollo S. Pozza D. Masiero S. Faggian D. Plebani M. Girelli M.E. Mantero F. Betterle C. Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis Clin. Endocrinol 2010 73 535 53910.1111/j.1365-2265.2009.03758.x20039895Search in Google Scholar

[19]Krysiak R., Okopien B.: The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab., 2011; 96: 2206-2215 Krysiak R. Okopien B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis J. Clin. Endocrinol. Metab 2011 96 2206 221510.1210/jc.2010-298621508145Search in Google Scholar

[20]Anastasilakis A.D., Toulis K.A., Nisianakis P., Goulis D.G., Kampas L., Valeri R.M., Oikonomou D., Tzellos T.G., Delaroudis S.: Selenomethionine treatment in patients with autoimmune thyroiditis: A prospective, quasi-randomised trial. Int. J. Clin. Pract., 2012; 66: 378-383 Anastasilakis A.D. Toulis K.A. Nisianakis P. Goulis D.G. Kampas L. Valeri R.M. Oikonomou D. Tzellos T.G. Delaroudis S. Selenomethionine treatment in patients with autoimmune thyroiditis: A prospective, quasi-randomised trial Int. J. Clin. Pract 2012 66 378 38310.1111/j.1742-1241.2011.02879.x22356267Search in Google Scholar

[21]Eskes S.A., Endert E., Fliers E., Birnie E., Hollenbach B., Schomburg L., Köhrle J., Wiersinga W.M.: Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin. Endocrinol., 2014; 80: 444-451 Eskes S.A. Endert E. Fliers E. Birnie E. Hollenbach B. Schomburg L. Köhrle J. Wiersinga W.M. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies Clin. Endocrinol 2014 80 444 45110.1111/cen.1228423844613Search in Google Scholar

[22]Pilli T., Cantara S., Schomburg L., Cenci V., Cardinale S., Heid E.C., Kühn E.C., Cevenini G., Sestini F., Fioravanti C., D’Hauw G., Pacini F.: IFNγ-inducible chemokines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: Comparison between two doses of selenomethionine (80 or 160 μg) versus placebo. Eur. Thyroid J., 2015; 4: 226-233 Pilli T. Cantara S. Schomburg L. Cenci V. Cardinale S. Heid E.C. Kühn E.C. Cevenini G. Sestini F. Fioravanti C. D’Hauw G. Pacini F. IFNγ-inducible chemokines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: Comparison between two doses of selenomethionine (80 or 160 μg) versus placebo Eur. Thyroid J 2015 4 226 23310.1159/000439589471642326835425Search in Google Scholar

[23]Esposito D., Rotondi M., Accardo G., Vallone G., Conzo G., Docimo G., Selvaggi F., Cappelli C., Chiovato L., Giugliano D., Pasquali D.: Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: Clinical results of a blinded placebo-controlled randomized prospective trial. J. Endocrinol. Invest., 2017; 40: 83-89 Esposito D. Rotondi M. Accardo G. Vallone G. Conzo G. Docimo G. Selvaggi F. Cappelli C. Chiovato L. Giugliano D. Pasquali D. Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: Clinical results of a blinded placebo-controlled randomized prospective trial J. Endocrinol. Invest 2017 40 83 8910.1007/s40618-016-0535-427572248Search in Google Scholar

[24]Pirola I., Rotondi M., Cristiano A., Maffezzoni F., Pasquali D., Marini F., Coperchini F., Paganelli M., Apostoli P., Chiovato L. i wsp.: Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study. Endocrinol. Diabetes Nutr., 2020; 67: 28-35 Pirola I. Rotondi M. Cristiano A. Maffezzoni F. Pasquali D. Marini F. Coperchini F. Paganelli M. Apostoli P. Chiovato L. i wsp. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study Endocrinol. Diabetes Nutr 2020 67 28 3510.1016/j.endinu.2019.03.01831196739Search in Google Scholar

[25]Manevska N., Stojanoski S., Makazlieva T.: Selenium treatment effect in auto-immune hashimoto thyroiditis in macedonian population. J. Endocrinol. Metab., 2019; 9: 22-28 Manevska N. Stojanoski S. Makazlieva T. Selenium treatment effect in auto-immune hashimoto thyroiditis in macedonian population J. Endocrinol. Metab 2019 9 22 2810.14740/jem551Search in Google Scholar

[26]Krohn K., Maier J., Paschke R.: Mechanisms of disease: Hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat. Clin. Pract. Endocrinol. Metab., 2007; 3: 713-720 Krohn K. Maier J. Paschke R. Mechanisms of disease: Hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors Nat. Clin. Pract. Endocrinol. Metab 2007 3 713 72010.1038/ncpendmet062117893690Search in Google Scholar

[27]Hendriksen M.A., van Raaij J.M., Geleijnse J.M., van den Hooven C.W., Ocké M.C., van der A D.: Monitoring salt and iodine intakes in Dutch adults between 2006 and 2010 using 24 h urinary sodium and iodine excretions. Public Health Nutr., 2014; 17: 1431-1438 Hendriksen M.A. van Raaij J.M. Geleijnse J.M. van den Hooven C.W. Ocké M.C. van der A D. Monitoring salt and iodine intakes in Dutch adults between 2006 and 2010 using 24 h urinary sodium and iodine excretions Public Health Nutr 2014 17 1431 143810.1017/S136898001300148123739290Search in Google Scholar

[28]Karunasinghe N., Han D.Y., Zhu S., Yu J., Lange K., Duan H., Medhora R., Singh N., Kan J., Alzaher W., Chen B., Ko S., Triggs C.M., Ferguson L.R.: Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: Relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr., 2012; 7: 179-190 Karunasinghe N. Han D.Y. Zhu S. Yu J. Lange K. Duan H. Medhora R. Singh N. Kan J. Alzaher W. Chen B. Ko S. Triggs C.M. Ferguson L.R. Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: Relationship to markers of oxidative stress in men from Auckland, New Zealand Genes Nutr 2012 7 179 19010.1007/s12263-011-0259-1331674522139612Search in Google Scholar

[29]Jablonska E., Gromadzinska J., Reszka E., Wasowicz W., Sobala W., Szeszenia-Dabrowska N., Boffetta P.: Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur. J. Nutr., 2009; 48: 383-386 Jablonska E. Gromadzinska J. Reszka E. Wasowicz W. Sobala W. Szeszenia-Dabrowska N. Boffetta P. Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans Eur. J. Nutr 2009 48 383 38610.1007/s00394-009-0023-019415410Search in Google Scholar

[30]de Farias C.R., Cardoso B.R., de Oliveira G.M., de Mello Guazzelli I.C., Catarino R.M., Chammas M.C., Cozzolino S.M., Knobel M.: A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J. Endocrinol. Invest., 2015; 38: 1065-1074 de Farias C.R.Cardoso B.R.de Oliveira G.M.de Mello Guazzelli I.C.Catarino R.M.Chammas M.C.Cozzolino S.M.Knobel M. A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes J. Endocrinol. Invest 2015 38 1065 107410.1007/s40618-015-0285-825894865Search in Google Scholar

[31]Curran J.E., Jowett J.B., Elliott K.S., Gao Y., Gluschenko K., Wang J., Abel Azim D.M., Cai G., Mahaney M.C., Comuzzie A.G. i wsp.: Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet., 2005; 37: 1234-1241 Curran J.E. Jowett J.B. Elliott K.S. Gao Y. Gluschenko K. Wang J. Abel Azim D.M. Cai G. Mahaney M.C. Comuzzie A.G. i wsp. Genetic variation in selenoprotein S influences inflammatory response Nat. Genet 2005 37 1234 124110.1038/ng165516227999Search in Google Scholar

[32]Bretz J.D., Arscott P.L., Myc A., Baker J.R.Jr.: Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J. Biol. Chem., 1999; 274: 25433-25438 Bretz J.D. Arscott P.L. Myc A. Baker J.R.Jr. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells J. Biol. Chem 1999 274 25433 2543810.1074/jbc.274.36.2543310464273Search in Google Scholar

[33]Mezosi E., Wang S.H., Utsugi S., Bajnok L., Bretz J.D., Gauger P.G., Thompson N.W., Baker J.R.Jr.: Interleukin-1β and tumor necrosis factor (TNF)-α sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity. J. Clin. Endocrinol. Metab., 2004; 89: 250-257 Mezosi E. Wang S.H. Utsugi S. Bajnok L. Bretz J.D. Gauger P.G. Thompson N.W. Baker J.R.Jr. Interleukin-1β and tumor necrosis factor (TNF)-α sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity J. Clin. Endocrinol. Metab 2004 89 250 25710.1210/jc.2003-03069714715858Search in Google Scholar

[34]Wang S.H., Van Antwerp M., Kuick R., Gauger P.G., Doherty G.M., Fan Y.Y., Baker J.R.Jr.: Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology, 2007; 148: 4844-4852 Wang S.H. Van Antwerp M. Kuick R. Gauger P.G. Doherty G.M. Fan Y.Y. Baker J.R.Jr. Microarray analysis of cytokine activation of apoptosis pathways in the thyroid Endocrinology 2007 148 4844 485210.1210/en.2007-012617640998Search in Google Scholar

[35]Antonelli A., Ferrari S.M., Giuggioli D., Ferrannini E., Ferri C., Fallahi P.: Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun. Rev., 2014; 13: 272-280 Antonelli A. Ferrari S.M. Giuggioli D. Ferrannini E. Ferri C. Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases Autoimmun. Rev 2014 13 272 28010.1016/j.autrev.2013.10.01024189283Search in Google Scholar

[36]Santos L.R., Durães C., Mendes A., Prazeres H., Alvelos M.I., Moreira C.S., Canedo P., Esteves C., Neves C., Carvalho D., Sobrinho-Simões M., Soares P.: A polymorphism in the promoter region of the selenoprotein Sgene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility. J. Clin. Endocrinol. Metab., 2014; 99: E719-E723 Santos L.R. Durães C. Mendes A. Prazeres H. Alvelos M.I. Moreira C.S. Canedo P. Esteves C. Neves C. Carvalho D. Sobrinho-Simões M. Soares P. A polymorphism in the promoter region of the selenoprotein Sgene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility J. Clin. Endocrinol. Metab 2014 99 E719 E72310.1210/jc.2013-353924471570Search in Google Scholar

[37]Wasniewska M., Vigone M.C., Cappa M., Aversa T., Rubino M., De Luca F., Study Group for Thyroid diseases of Italian Society for Pediatric Endocrinology: Acute suppurative thyroiditis in childhood: Relative frequency among thyroid inflammatory diseases. J. Endocrinol. Invest., 2007; 30: 346-347 Wasniewska M. Vigone M.C. Cappa M. Aversa T. Rubino M.De Luca F. Study Group for Thyroid diseases of Italian Society for Pediatric Endocrinology: Acute suppurative thyroiditis in childhood: Relative frequency among thyroid inflammatory diseases J. Endocrinol. Invest 2007 30 346 34710.1007/BF0334630317556874Search in Google Scholar

[38]De Luca F., Santucci S., Corica D., Pitrolo E., Romeo M., Aversa T.: Hashimoto’s thyroiditis in childhood: Presentation modes and evolution over time. Ital. J. Pediatr., 2013; 39: 8 De Luca F. Santucci S. Corica D. Pitrolo E. Romeo M. Aversa T. Hashimoto’s thyroiditis in childhood: Presentation modes and evolution over time Ital. J. Pediatr 2013 39 810.1186/1824-7288-39-8356797623363471Search in Google Scholar

[39]Bonfig W., Gärtner R., Schmidt H.: Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. Sci. World J., 2010; 10: 990-996 Bonfig W. Gärtner R. Schmidt H. Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis Sci. World J 2010 10 990 99610.1100/tsw.2010.91576381620526530Search in Google Scholar

[40]Nourbakhsh M., Ahmadpour F., Chahardoli B., Malekpour-Dehkordi Z., Nourbakhsh M., Hosseini-Fard S.R., Doustimotlagh A., Golestani A., Razzaghy-Azar M.: Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto’s thyroiditis and hypothyroidism. J. Trace Elem. Med. Biol., 2016; 34: 10-14 Nourbakhsh M. Ahmadpour F. Chahardoli B. Malekpour-Dehkordi Z. Nourbakhsh M. Hosseini-Fard S.R. Doustimotlagh A. Golestani A. Razzaghy-Azar M. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto’s thyroiditis and hypothyroidism J. Trace Elem. Med. Biol 2016 34 10 1410.1016/j.jtemb.2015.10.00326854239Search in Google Scholar

[41]Stagnaro-Green A.: Approach to the patient with postpartum thyroiditis. J. Clin. Endocrinol. Metab., 2012; 97: 334-342 Stagnaro-Green A. Approach to the patient with postpartum thyroiditis J. Clin. Endocrinol. Metab 2012 97 334 34210.1210/CAEM3.9781936704866.ch4Search in Google Scholar

[42]Korevaar T.I., Schalekamp-Timmermans S., de Rijke Y.B., Visser W.E., Visser W., de Muinck Keizer-Schrama S.M., Hofman A., Ross H.A., Hooijkaas H., Tiemeier H., Bongers-Schokking J.J., Jaddoe V.W., Visser T.J., Steegers E.A., Medici M., Peeters R.P.: Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: The generation R study. J. Clin. Endocrinol. Metab., 2013; 98: 4382-4390 Korevaar T.I. Schalekamp-Timmermans S. de Rijke Y.B. Visser W.E. Visser W. de Muinck Keizer-Schrama S.M. Hofman A. Ross H.A. Hooijkaas H. Tiemeier H. Bongers-Schokking J.J. Jaddoe V.W. Visser T.J. Steegers E.A. Medici M. Peeters R.P. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: The generation R study J. Clin. Endocrinol. Metab 2013 98 4382 439010.1210/jc.2013-285524037884Search in Google Scholar

[43]Thangaratinam S., Tan A., Knox E., Kilby M.D., Franklyn J., Coomarasamy A.: Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence. BMJ, 2011; 342: d2616 Thangaratinam S. Tan A. Knox E. Kilby M.D. Franklyn J. Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence BMJ 2011 342 d261610.1097/01.aoa.0000414067.82440.e6Search in Google Scholar

[44]Negro R., Greco G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H.: The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J. Clin. Endocrinol. Metab., 2007; 92: 1263-1268 Negro R. Greco G. Mangieri T. Pezzarossa A. Dazzi D. Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies J. Clin. Endocrinol. Metab 2007 92 1263 126810.1210/jc.2006-182117284630Search in Google Scholar

[45]Mao J., Pop V.J., Bath S.C., Vader H.L., Redman C.W., Rayman M.P.: Effect of low‑dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild‑to‑moderate iodine deficiency. Eur. J. Nutr., 2016; 55: 55-61 Mao J. Pop V.J. Bath S.C. Vader H.L. Redman C.W. Rayman M.P. Effect of low‑dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild‑to‑moderate iodine deficiency Eur. J. Nutr 2016 55 55 6110.1007/s00394-014-0822-9473778625524327Search in Google Scholar

[46]Karanikas G., Schuetz M., Wahl K., Paul M., Kontur S., Pietschmann P., Kletter K., Dudczak R., Willheim M.: Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditis. Clin. Endocrinol., 2005; 63: 191-196 Karanikas G. Schuetz M. Wahl K. Paul M. Kontur S. Pietschmann P. Kletter K. Dudczak R. Willheim M. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditis Clin. Endocrinol 2005 63 191 19610.1111/j.1365-2265.2005.02324.x16060913Search in Google Scholar

[47]Pállinger E., Csaba G.: A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells. Immunology, 2008; 123: 584-589 Pállinger E. Csaba G. A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells Immunology 2008 123 584 58910.1111/j.1365-2567.2007.02731.x243331618005034Search in Google Scholar

[48]Rotondi M., Chiovato L., Romagnani S., Serio M., Romagnani P.: Role of chemokines in endocrine autoimmune diseases. Endocr. Rev., 2007; 28: 492-520 Rotondi M. Chiovato L. Romagnani S. Serio M. Romagnani P. Role of chemokines in endocrine autoimmune diseases Endocr. Rev 2007 28 492 52010.1210/er.2006-004417475924Search in Google Scholar

[49]Antonelli A., Ferrari S.M., Frascerra S., Di Domenicantonio A., Nicolini A., Ferrari P., Ferrannini E., Fallahi P.: Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. J. Clin. Endocrinol. Metab., 2011; 96: 1859-1863 Antonelli A. Ferrari S.M. Frascerra S. Di Domenicantonio A. Nicolini A. Ferrari P. Ferrannini E. Fallahi P. Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis J. Clin. Endocrinol. Metab 2011 96 1859 186310.1210/jc.2010-290521470996Search in Google Scholar

[50]Antonelli A., Ferrari S.M., Frascerra S., Galetta F., Franzoni F., Corrado A., Miccoli M., Benvenga S., Paolicchi A., Ferrannini E., Fallahi P.: Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. Cytokine, 2011; 55: 288-293 Antonelli A. Ferrari S.M. Frascerra S. Galetta F. Franzoni F. Corrado A. Miccoli M. Benvenga S. Paolicchi A. Ferrannini E. Fallahi P. Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10 Cytokine 2011 55 288 29310.1016/j.cyto.2011.04.02221601475Search in Google Scholar

[51]Antonelli A., Ferri C., Ferrari S.M., Frascerra S., Ruffilli I., Caponi L., Ulisse S., Miccoli M., Miccoli P., Fallahi P.: High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10. J. Interferon Cytokine Res., 2012; 32: 74-80 Antonelli A. Ferri C. Ferrari S.M. Frascerra S. Ruffilli I. Caponi L. Ulisse S. Miccoli M. Miccoli P. Fallahi P. High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10 J. Interferon Cytokine Res 2012 32 74 8010.1089/jir.2011.005122168752Search in Google Scholar

[52]Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Buonamano A., Ferrannini E., Serio M.: High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J. Clin. Endocrinol. Metab., 2004; 89: 5496-5499 Antonelli A. Rotondi M. Fallahi P. Romagnani P. Ferrari S.M. Buonamano A. Ferrannini E. Serio M. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism J. Clin. Endocrinol. Metab 2004 89 5496 549910.1210/jc.2004-097715531503Search in Google Scholar

[53]Nanba T., Watanabe M., Inoue N., Iwatani Y.: Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid, 2009; 19: 495-501 Nanba T. Watanabe M. Inoue N. Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease Thyroid 2009 19 495 50110.1089/thy.2008.042319415997Search in Google Scholar

[54]Phenekos C., Vryonidou A., Gritzapis A.D., Baxevanis C.N., Goula M., Papamichail M.: Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2). Neuroimmunomodulation, 2004; 11: 209-213 Phenekos C. Vryonidou A. Gritzapis A.D. Baxevanis C.N. Goula M. Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2) Neuroimmunomodulation 2004 11 209 21310.1159/00007843815249726Search in Google Scholar

[55]Konca Degertekin C., Aktas Yilmaz B., Balos Toruner F., Kalkanci A., Turhan Iyidir O., Fidan I., Yesilyurt E., Cakır N., Kustimur S., Arslan M.: Circulating Th17 cytokine levels are altered in Hashimoto’s thyroiditis. Cytokine, 2016; 80: 13-17 Konca Degertekin C. Aktas Yilmaz B. Balos Toruner F. Kalkanci A. Turhan Iyidir O. Fidan I. Yesilyurt E. Cakır N. Kustimur S. Arslan M. Circulating Th17 cytokine levels are altered in Hashimoto’s thyroiditis Cytokine 2016 80 13 1710.1016/j.cyto.2016.02.01126928603Search in Google Scholar

[56]Li D., Cai W., Gu R., Zhang Y., Zhang H., Tang K., Xu P., Katirai F., Shi W., Wang L., Huang T., Huang B.: Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients. Clin. Immunol., 2013; 149: 411-420 Li D. Cai W. Gu R. Zhang Y. Zhang H. Tang K. Xu P. Katirai F. Shi W. Wang L. Huang T. Huang B. Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients Clin. Immunol 2013 149 411 42010.1016/j.clim.2013.10.00124211715Search in Google Scholar

[57]Xue H., Yu X., Ma L., Song S., Li Y., Zhang L., Yang T., Liu H.: The possible role of CD4⁺CD25^highFoxp3⁺/CD4⁺IL-17A⁺ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. Endocrine, 2015; 50: 665-673 Xue H. Yu X. Ma L. Song S. Li Y. Zhang L. Yang T. Liu H. The possible role of CD4⁺CD25^highFoxp3⁺/CD4⁺IL-17A⁺ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis Endocrine 2015 50 665 67310.1007/s12020-015-0569-y25771887Search in Google Scholar

[58]Wichman J., Winther K.H., Bonnema S.J., Hegedüs L.: Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis. Thyroid, 2016; 26: 1681-1692 Wichman J. Winther K.H. Bonnema S.J. Hegedüs L. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis Thyroid 2016 26 1681 169210.1089/thy.2016.025627702392Search in Google Scholar

[59]Winther K.H., Wichman J.E.M., Bonnema S.J., Hegedüs L.: Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine, 2017; 55: 376-385 Winther K.H. Wichman J.E.M. Bonnema S.J. Hegedüs L. Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis Endocrine 2017 55 376 38510.1007/s12020-016-1098-z527287727683225Search in Google Scholar